Krystal Biotech KRYS
NASDAQ KRYS
$334.04 -1.02 (-0.30%)
As of: Sep 30, 2026 · 1:35 PM EDT

Krystal Biotech, Inc. (KRYS) EV to EBIT (2024 - 2026)

Updated

Krystal Biotech's (KRYS) EV to EBIT came in at 51.35 for Q2 2026, up 117.4% from 23.62 a year earlier and up 35.3% from the prior quarter.

Analysis

Krystal Biotech, Inc. (KRYS) EV to EBIT (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EV to EBIT at Krystal Biotech was 39.30, up 267.6% year-over-year; for FY2025, it came in at 39.49, down 33.7% from FY2024.

  • In prior years, Krystal Biotech's EV to EBIT was 59.52 in FY2024.
  • The Q2 2026 figure stands as the highest quarterly EV to EBIT since Q4 2024.
  • On a year-over-year basis, EV to EBIT increased in 1 of the last four quarters, with an average decline of 2.5%.
  • According to Business Quant data, EV to EBIT for the three prior quarters was 37.94 (Q1 2026), 39.49 (Q4 2025) and 27.69 (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.35
Mar 31, 2026 37.94
Dec 31, 2025 39.49
Sep 30, 2025 27.69
Jun 30, 2025 23.62
Mar 31, 2025 42.27
Dec 31, 2024 59.54
Sep 30, 2024 168.33
API Access

Krystal Biotech, Inc. EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=KRYS&period=max&api_key=YOUR_API_KEY